The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions
- PMID: 20161875
- PMCID: PMC2816365
The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions
Abstract
Toluidine blue stain is used as a marker to differentiate lesions at high risk of progression in order to improve early diagnosis of oropharyngeal carcinomas. This study focused on 45 oral mucosal lesions in 32 patients (13 female, 19 male). In 9 cases, multiple biopsies were collected. Of the 45 lesions examined, 26 (57.0%) were defined clinically benign, while 19 (42.3%) were defined as suspected lesions (premalignant or malignant). According to the clinical examination, the sensitivity was 53% (16/30) and for toluidine blue staining 96.2% (26/27) (p = 0.0007). The specificity was 80% (12/15) for clinical examination and 77.7% (14/15) for toluidine blue staining (p = 0.79). In conclusion toluidine blue stain has been shown to be a reliable aid when clinical examination is unable to differentiate lesions at high risk of progression and then it improves early diagnosis for oral cavity and oropharyngeal cancer.
Allo scopo di migliorare la diagnosi precoce dei carcinomi del cavo orale e dell’orofaringe abbiamo ritenuto opportuno verificare l’attendibilità della colorazione con toluidina come marker per differenziare le lesioni ad alto rischio di progressione. Lo studio ha preso in considerazione 45 lesioni del cavo orale e dell’orofaringe che riguardavano 32 pazienti. In 9 casi venivano eseguite biopsie multiple, 19 pazienti erano di sesso maschile e 13 di sesso femminile. Le lesioni definite clinicamente benigne erano 26/45 (57,0%) mentre 19 (42,3%) erano definite sospette (premaligne o maligne). Comparando la valutazione dell’esame obiettivo e della colorazione con toluidina delle lesioni con i risultati dell’esame istologico la sensibilità della toluidina è risultata essere più attendibile rispetto all’esame obiettivo, con una differenza statisticamente significativa. La valutazione della specificità non ha mostrato invece differenze statisticamente significative. La colorazione con toluidina sembra dare un contributo significativo nei casi in cui l’esame obiettivo non è sufficiente a differenziare lesioni ad alto rischio di progressione.
Keywords: Malignant tumours; Oral cavity; Oropharynx; Precancerous lesions.
Similar articles
-
A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.Quintessence Int. 2012 Jan;43(1):51-9. Quintessence Int. 2012. PMID: 22259809
-
Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.Acta Cytol. 2007 Sep-Oct;51(5):788-94. doi: 10.1159/000325843. Acta Cytol. 2007. PMID: 17910350
-
Toluidine blue staining in the detection of oral precancerous and malignant lesions.Oral Surg Oral Med Oral Pathol. 1984 Apr;57(4):379-82. doi: 10.1016/0030-4220(84)90154-3. Oral Surg Oral Med Oral Pathol. 1984. PMID: 6200814
-
Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.Head Neck. 2007 Oct;29(10):948-58. doi: 10.1002/hed.20637. Head Neck. 2007. PMID: 17764090 Review.
-
Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers.CA Cancer J Clin. 1995 Nov-Dec;45(6):328-51. doi: 10.3322/canjclin.45.6.328. CA Cancer J Clin. 1995. PMID: 7583906 Review.
Cited by
-
Efficacy of non-invasive diagnostic methods in the diagnosis and screening of oral cancer and precancer.Braz J Otorhinolaryngol. 2022 Nov-Dec;88(6):937-947. doi: 10.1016/j.bjorl.2020.12.019. Epub 2021 Feb 13. Braz J Otorhinolaryngol. 2022. PMID: 33642212 Free PMC article.
-
Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.JAMA Otolaryngol Head Neck Surg. 2016 Apr;142(4):330-8. doi: 10.1001/jamaoto.2015.3617. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 26892902 Free PMC article.
-
Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association.J Am Dent Assoc. 2017 Nov;148(11):797-813.e52. doi: 10.1016/j.adaj.2017.08.045. J Am Dent Assoc. 2017. PMID: 29080605 Free PMC article.
-
Toluidine Blue 0.05% Vital Staining for the Diagnosis of Ocular Surface Squamous Neoplasia in Kenya.JAMA Ophthalmol. 2015 Nov;133(11):1314-21. doi: 10.1001/jamaophthalmol.2015.3345. JAMA Ophthalmol. 2015. PMID: 26378623 Free PMC article.
-
Accuracy of special histochemical staining methods in diagnosis of oral pathology: A systematic review and meta-analysis.Dent Res J (Isfahan). 2024 Jul 12;21:34. eCollection 2024. Dent Res J (Isfahan). 2024. PMID: 39188398 Free PMC article. Review.
References
-
- Jemal A, Thimas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:181-2. - PubMed
-
- World Health Organization Collaborating Center for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-39. - PubMed
-
- Banoczy J, Sugar L. Longitudinal studies on oral leukoplakia. J Oral Pathol 1972;1:265-9. - PubMed
-
- Chiesa F, Tradati N, Sala L, Costa L, Podrecca S, Baracchi P, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 1990;116:177-80. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources